Jane M. Liebschutz, MD, MPH, FACP

  • Director, Center for Research on Health Care
  • Chief, Division of General Internal Medicine
  • Falk Chair in Ambulatory Medicine
  • Professor of Medicine with Tenure

Board certified in internal medicine and addiction medicine, Dr. Liebschutz is a primary care physician, substance use researcher, and administrator. She serves as Chief, Division of General Internal Medicine. Prior to assuming her role as Chief at University of Pittsburgh in 2017, she was Associate Chief in the Section of General Internal Medicine at Boston Medical Center. She entered medicine to pursue public health and social justice and has never waivered from that passion. Dr. Liebschutz began her research career studying the health impacts of interpersonal violence, including pain and substance use. Her academic career developed at the same time as the national opioid crisis, which led her to more opportunities to study and try to improve and ameliorate the harms of opioid use through clinical care, education, and research. She has had a dual interest in faculty development, research education, and mentorship, having served as the Director of the Primary Care Academic Research Fellowship and Preventive Medicine Residency for more than 15 years at Boston University. She is passionate about leadership and helping others reach their potential, whether patients, staff, trainees, or colleagues. 

Dr. Liebschutz’s research agenda focuses on prevention and treatment of opioid use disorders in medical settings, with a focus on opioid prescribing for pain and treatment of opioid use disorders. She uses implementation science and health services research methods. She has served as PI and co-investigator on multiple NIDA funded RO1 and U studies, including cohort studies and randomized controlled trials in inpatient, primary care, and HIV care settings. She is PI of the Appalachian Node of NIDA Clinical Trials Network. Dr. Liebschutz is a national lecturer and educator on opioid prescribing and developed the website, www.opioidresources.org, a resource for opioid prescribing in the primary care setting. She has been a certified buprenorphine prescriber since 2006, managing an active panel of opioid-dependent patients within her primary care internal medicine practice and serving as a consultant on the inpatient Addiction Medicine Consult service. She is founder and chair of Bridging Connections in Addiction Research at the University of Pittsburgh, a network of multi-disciplinary addiction researchers for collaborative research and training. She advocates for harm reduction and is passionate about physician wellness.

Dr. Liebschutz grew up in Rochester, NY and spent 30 years in Boston (26 at Boston Medical Center), where she became a card-carrying member of Red Sox nation. She and her husband, Roger, have three young adult children and a dog named Sadie. 

Education & Training

  • BA, East Asian Studies: China, Yale University, 1983
  • MD, Harvard Medical School, 1991
  • MPH, Epidemiology and Biostatistics, Boston University School of Public Health, 1998
  • Internal Medicine Residency Program, Boston City Hospital, 1994
  • Preventive Medicine Residency, Boston University Medical Center, 1998
  • General Medicine Fellowship Program, Boston University Medical Center, 1998
  • Faculty Fellow, Prevention and Other Drug Abuse Faculty Development Program, Boston University Medical Center, 2001

Representative Publications

 

Liebschutz JM, Crooks D, Herman D, Anderson B, Tsui J, Meshesha LZ, Dossabhoy S**, Stein MD. Buprenorphine Treatment for Hospitalized, Opioid-Dependent Patients: A Randomized Clinical Trial. JAMA-Internal Medicine. 2014 Aug;174(8):1369-1376. 

A randomized controlled trial showed that initiating buprenorphine treatment for hospitalized patients with opioid use disorder and actively linking them to post-discharge buprenorphine treatment was successful in more than 70% of the time compared to those with only a detoxification with buprenorphine.  

Liebschutz JM, Xuan Z, Shanahan CW, LaRochelle M, Keosaian J, Deers D, Guara G, O’Connor K, Alford DP, Parker V, Weiss RD, Samet JH, Crosson J, Cushman PA**, Lasser KE. Improving Adherence to Long-term Opioid Therapy Guidelines to Reduce Opioid Misuse in Primary Care: A Cluster-Randomized Trial. JAMA Intern Med. 2017 Sept 1;177(9):1265-1272. 

A multisite cluster randomized controlled trial demonstrated that collaborative care with a nurse-care manager, academic detailing and population management improved guideline concordant care for individuals in long-term opioid treatment for chronic pain.

Merlin JS, Young SR, Starrels JL, Azari S, Edelman EJ, Pomeranz J, Roy P, Saini S, Becker WC, Liebschutz JM. Managing Concerning Behaviors in Patients Prescribed Opioids for Chronic Pain: a Delphi study. J Gen Int Med, 2018 Feb:33(2):166-176. 

Using delphi-methods, national experts classified concerning behaviors and developed agreement for suggested approaches for patients prescribed opioids for chronic pain who demonstrate concerning behaviors.

Stein MD, Phillips KT, Herman DS, Keosaian J, Stewart C, Anderson BJ, Weinstein Z, Liebschutz JM. Skin Cleaning among Hospitalized Persons Who Inject Drugs: A randomized controlled trial. Addiction. 2021 May;116(5):1122-1130. 

This randomized controlled trial examined whether a psychoeducational intervention for hospitalized individuals with injection drug use would decrease skin and soft tissue infections.

Click here for a more complete bibliography of Dr. Liebschutz's works.

Research Interests

  • Primary care
  • Addiction medicine
  • Clinical trials
  • Wellness